Stay updated on Safety of Tarlatamab in Adults With SCLC Clinical Trial
Sign up to get notified when there's something new on the Safety of Tarlatamab in Adults With SCLC Clinical Trial page.

Latest updates to the Safety of Tarlatamab in Adults With SCLC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedAdded revision entry v3.5.2 and removed revision v3.5.0 from the record history.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check39 days agoChange DetectedAdded revision: v3.5.0 to the history and removed revision: v3.4.3.SummaryDifference0.0%

- Check46 days agoChange Detected- Revision history updated: v3.4.3 added and v3.4.2 removed.SummaryDifference0.0%

- Check75 days agoChange DetectedAdded Revision: v3.4.2. Removed prior non-critical notices including a government funding/operating status message (Revision: v3.4.1).SummaryDifference0.3%

- Check82 days agoChange DetectedA site-wide funding notice was added and the record version updated from v3.4.0 to v3.4.1, with no changes to study details or record content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check89 days agoChange DetectedThe Record History page now includes a glossary option and color-coded change highlights (green for additions, red for deletions) with an updated revision label (v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Safety of Tarlatamab in Adults With SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Tarlatamab in Adults With SCLC Clinical Trial page.